Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2008 1
2014 1
2015 1
2016 2
2017 4
2018 4
2019 2
2020 6
2021 4
2022 1
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis.
Bieber T, Simpson EL, Silverberg JI, Thaçi D, Paul C, Pink AE, Kataoka Y, Chu CY, DiBonaventura M, Rojo R, Antinew J, Ionita I, Sinclair R, Forman S, Zdybski J, Biswas P, Malhotra B, Zhang F, Valdez H; JADE COMPARE Investigators. Bieber T, et al. N Engl J Med. 2021 Mar 25;384(12):1101-1112. doi: 10.1056/NEJMoa2019380. N Engl J Med. 2021. PMID: 33761207 Clinical Trial.
Novel Therapeutic Approaches to Atopic Dermatitis.
Osinka K, Dumycz K, Kwiek B, Feleszko W. Osinka K, et al. Among authors: kwiek b. Arch Immunol Ther Exp (Warsz). 2018 Jun;66(3):171-181. doi: 10.1007/s00005-017-0487-1. Epub 2017 Aug 31. Arch Immunol Ther Exp (Warsz). 2018. PMID: 28861617 Free article. Review.
Keratoacanthoma (KA): An update and review.
Kwiek B, Schwartz RA. Kwiek B, et al. J Am Acad Dermatol. 2016 Jun;74(6):1220-33. doi: 10.1016/j.jaad.2015.11.033. Epub 2016 Feb 4. J Am Acad Dermatol. 2016. PMID: 26853179 Review.
Efficacy and Safety of Candidate Biosimilar CT-P43 Versus Originator Ustekinumab in Moderate to Severe Plaque Psoriasis: 28-Week Results of a Randomised, Active-Controlled, Double-Blind, Phase III Study.
Papp KA, Lebwohl MG, Thaçi D, Jaworski J, Kwiek B, Trefler J, Dudek A, Szepietowski JC, Reznichenko N, Narbutt J, Baran W, Kolinek J, Daniluk S, Bartnicka-Maslowska K, Reich A, Andrashko Y, Kim S, Bae Y, Jeon D, Jung J, Lee H, Pyo T, Ko W. Papp KA, et al. Among authors: kwiek b. BioDrugs. 2024 Jan;38(1):121-131. doi: 10.1007/s40259-023-00630-5. Epub 2023 Nov 22. BioDrugs. 2024. PMID: 37991693 Free PMC article. Clinical Trial.
The Assessment of Activity of Antiseptic Agents against Biofilm of Staphylococcus aureus Measured with the Use of Processed Microscopic Images.
Krasowski G, Migdał P, Woroszyło M, Fijałkowski K, Chodaczek G, Czajkowska J, Dudek B, Nowicka J, Oleksy-Wawrzyniak M, Kwiek B, Paleczny J, Brożyna M, Junka A. Krasowski G, et al. Among authors: kwiek b. Int J Mol Sci. 2022 Nov 4;23(21):13524. doi: 10.3390/ijms232113524. Int J Mol Sci. 2022. PMID: 36362310 Free PMC article.
Lack of prolidase causes a bone phenotype both in human and in mouse.
Besio R, Maruelli S, Gioia R, Villa I, Grabowski P, Gallagher O, Bishop NJ, Foster S, De Lorenzi E, Colombo R, Diaz JL, Moore-Barton H, Deshpande C, Aydin HI, Tokatli A, Kwiek B, Kasapkara CS, Adisen EO, Gurer MA, Di Rocco M, Phang JM, Gunn TM, Tenni R, Rossi A, Forlino A. Besio R, et al. Among authors: kwiek b. Bone. 2015 Mar;72:53-64. doi: 10.1016/j.bone.2014.11.009. Epub 2014 Nov 20. Bone. 2015. PMID: 25460580
22 results